Voya Investment Management LLC Pacira Bio Sciences, Inc. Transaction History

Voya Investment Management LLC

  • $71.9 Billion
  • Q1 2025

A detailed history of Voya Investment Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 12,468 shares of PCRX stock, worth $308,458. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,468
Previous 12,468 -0.0%
Holding current value
$308,458
Previous $309,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

42 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$18.33 - $27.25 $27,128 - $40,330
-1,480 Reduced 10.61%
12,468 $309,000
Q4 2024

Feb 14, 2025
SELL
$15.3 - $20.33 $457,485 - $607,887
-29,901 Reduced 68.19%
13,948 $262,000
Q3 2024

Feb 07, 2025
BUY
$11.7 - $28.46 $81,455 - $198,138
6,962 Added 18.87%
43,849 $660,000
Q3 2024

Nov 14, 2024
BUY
$11.7 - $28.46 $81,455 - $198,138
6,962 Added 18.87%
43,849 $660,000
Q2 2024

Feb 07, 2025
SELL
$25.5 - $31.51 $2,754 - $3,403
-108 Reduced 0.29%
36,887 $1.06 Million
Q2 2024

Dec 03, 2024
SELL
$25.5 - $31.51 $177,531 - $219,372
-6,962 Reduced 15.88%
36,887 $1.06 Million
Q2 2024

Aug 14, 2024
SELL
$25.5 - $31.51 $2,754 - $3,403
-108 Reduced 0.29%
36,887 $1.06 Million
Q1 2024

Feb 07, 2025
SELL
$27.7 - $35.48 $189,855 - $243,179
-6,854 Reduced 15.63%
36,995 $1.08 Million
Q1 2024

Dec 06, 2024
SELL
$27.7 - $35.48 $189,855 - $243,179
-6,854 Reduced 15.63%
36,995 $1.08 Million
Q1 2024

May 15, 2024
BUY
$27.7 - $35.48 $86,396 - $110,662
3,119 Added 9.21%
36,995 $1.08 Million
Q4 2023

Feb 07, 2025
BUY
$26.32 - $34.31 $201,848 - $263,123
7,669 Added 29.26%
33,876 $1.14 Million
Q4 2023

Feb 14, 2024
BUY
$26.32 - $34.31 $201,848 - $263,123
7,669 Added 29.26%
33,876 $1.14 Million
Q3 2023

Feb 07, 2025
BUY
$30.68 - $40.09 $6,013 - $7,857
196 Added 0.75%
26,207 $804,000
Q3 2023

Nov 14, 2023
BUY
$30.68 - $40.09 $6,013 - $7,857
196 Added 0.75%
26,207 $804,000
Q2 2023

Feb 07, 2025
BUY
$36.12 - $47.5 $25,753 - $33,867
713 Added 2.82%
26,011 $1.04 Million
Q2 2023

Aug 14, 2023
BUY
$36.12 - $47.5 $25,753 - $33,867
713 Added 2.82%
26,011 $1.04 Million
Q1 2023

Feb 07, 2025
SELL
$35.53 - $43.38 $659,117 - $804,742
-18,551 Reduced 42.31%
25,298 $1.03 Million
Q1 2023

May 15, 2023
SELL
$35.53 - $43.38 $6.26 Million - $7.64 Million
-176,147 Reduced 87.44%
25,298 $1.03 Million
Q4 2022

Feb 07, 2025
SELL
$38.19 - $57.45 $4.73 Million - $7.11 Million
-123,817 Reduced 36.8%
212,601 $8.21 Million
Q4 2022

Feb 14, 2023
SELL
$38.19 - $57.45 $4.42 Million - $6.64 Million
-115,661 Reduced 36.47%
201,445 $7.78 Million
Q3 2022

Feb 07, 2025
BUY
$51.24 - $58.89 $15 Million - $17.2 Million
292,569 Added 667.22%
336,418 $17.9 Million
Q3 2022

Mar 03, 2023
BUY
$51.24 - $58.89 $5.93 Million - $6.81 Million
115,661 Added 57.42%
317,106 $16.9 Million
Q3 2022

Nov 14, 2022
BUY
$51.24 - $58.89 $11.3 Million - $12.9 Million
219,747 Added 225.71%
317,106 $16.9 Million
Q2 2022

Aug 15, 2022
SELL
$51.49 - $81.64 $12.1 Million - $19.2 Million
-235,409 Reduced 70.74%
97,359 $5.68 Million
Q1 2022

May 16, 2022
BUY
$60.03 - $76.49 $18.3 Million - $23.3 Million
304,266 Added 1067.53%
332,768 $25.4 Million
Q4 2021

Feb 14, 2022
SELL
$47.97 - $62.21 $100,017 - $129,707
-2,085 Reduced 6.82%
28,502 $1.72 Million
Q3 2021

Nov 15, 2021
SELL
$54.64 - $61.3 $1,256 - $1,409
-23 Reduced 0.08%
30,587 $1.71 Million
Q2 2021

Aug 16, 2021
SELL
$59.18 - $69.99 $94,924 - $112,263
-1,604 Reduced 4.98%
30,610 $1.86 Million
Q1 2021

May 17, 2021
BUY
$59.31 - $78.82 $28,765 - $38,227
485 Added 1.53%
32,214 $2.26 Million
Q4 2020

Feb 16, 2021
BUY
$50.47 - $66.26 $361,768 - $474,951
7,168 Added 29.18%
31,729 $1.9 Million
Q3 2020

Nov 16, 2020
SELL
$51.97 - $63.0 $10,913 - $13,230
-210 Reduced 0.85%
24,561 $1.48 Million
Q2 2020

Aug 14, 2020
SELL
$30.8 - $52.47 $183,075 - $311,881
-5,944 Reduced 19.35%
24,771 $1.3 Million
Q1 2020

May 15, 2020
BUY
$28.4 - $50.7 $312,400 - $557,700
11,000 Added 55.8%
30,715 $1.03 Million
Q4 2019

Feb 14, 2020
BUY
$36.31 - $46.83 $130,352 - $168,119
3,590 Added 22.26%
19,715 $893,000
Q2 2019

Aug 14, 2019
SELL
$36.57 - $47.97 $7,972 - $10,457
-218 Reduced 1.33%
16,125 $701,000
Q1 2019

May 15, 2019
SELL
$36.47 - $42.17 $13,384 - $15,476
-367 Reduced 2.2%
16,343 $622,000
Q4 2018

Feb 14, 2019
BUY
$41.31 - $52.16 $21,481 - $27,123
520 Added 3.21%
16,710 $719,000
Q3 2018

Nov 14, 2018
SELL
$32.85 - $52.0 $5,748 - $9,100
-175 Reduced 1.07%
16,190 $796,000
Q2 2018

Aug 14, 2018
SELL
$27.5 - $39.8 $32,725 - $47,362
-1,190 Reduced 6.78%
16,365 $524,000
Q1 2018

May 15, 2018
SELL
$29.98 - $46.35 $17.1 Million - $26.5 Million
-570,892 Reduced 97.02%
17,555 $547,000
Q4 2017

Feb 14, 2018
SELL
$31.85 - $46.95 $81,153 - $119,628
-2,548 Reduced 0.43%
588,447 $26.9 Million
Q3 2017

Nov 14, 2017
BUY
$35.7 - $39.5 $21.1 Million - $23.3 Million
590,995
590,995 $22.2 Million

Others Institutions Holding PCRX

# of Institutions
254
Shares Held
51.1M
Call Options Held
157K
Put Options Held
139K
View Full List

About Pacira BioSciences, Inc.

PCRX Quotes by TradingView
  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.13B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email